| Income Statement |
| Operating Expenses | 4.49M |
|
| Research and Development Expense | 2.75M |
| Selling, General and Administrative Expense | 1.75M |
| Operating Income | -4.49M |
| Net Income | -4.46M |
| Net Income Common Stock | -4.46M |
| Net Income Common Stock (USD) | -4.46M |
| Consolidated Income | -4.46M |
| Earnings per Basic Share | -0.64 |
| Earnings per Basic Share (USD) | -0.64 |
| Earnings per Diluted Share | -0.64 |
| Earning Before Interest & Taxes (EBIT) | -4.46M |
| Earning Before Interest & Taxes (USD) | -4.46M |
| Weighted Average Shares | 6.95M |
| Weighted Average Shares Diluted | 6.95M |
| Balance Sheet |
| Cash and Equivalents | 18.05M |
| Cash and Equivalents (USD) | 18.05M |
| Current Assets | 18.80M |
| Total Assets | 20.31M |
| Current Liabilities | 3.35M |
| Total Liabilities | 3.38M |
| Accumulated Retained Earnings (Deficit) | -175.49M |
| Shareholders Equity | 16.93M |
| Shareholders Equity (USD) | 16.93M |
| Assets Non-Current | 1.50M |
| Inventory | 1.50M |
| Liabilities Non-Current | 22.50K |
| Trade and Non-Trade Payables | 1.66M |
| Cash Flow |
| Net Cash Flow from Financing | 13.36M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.22M |
| Issuance (Purchase) of Equity Shares | 13.36M |
| Net Cash Flow from Operations | -3.14M |
| Share Based Compensation | 73.43K |